/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.37%
Natural Gas
+2.32%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.09%
VIX
N/A
Economic Calendar
EUR/USD
-0.37%
Natural Gas
+2.32%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.09%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
US GDP for Previous Quarter Adjusted Upward to a Robust Annual 3.4%
about 3 hours ago
The Market News Today: US GDP Forecast at 3.2%, Eyes on Fed and Market Response
about 6 hours ago
German Retail Sales Tumble 1.9% in February Driving ECB Rate Cut Bets
about 11 hours ago
Georgia’s Credit Outlook Constrained By Geopolitical Sensitivities, Institutional Risks
1 day ago
Crude Oil Inventories Rise By 3.2 Million Barrels, Exceeding Analyst Expectations
1 day ago
Bank of England FPC Reveals Global Risks and UK Economic Challenges
1 day ago
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Gains Ground As Traders Bet On Rising Demand
31 minutes ago
Gold, Silver, Platinum Forecasts – Gold Tests Historic Highs
about 2 hours ago
Is The Pullback In Gold A Perfect Buying Opportunity?
about 2 hours ago
EUR/USD, GBP/USD, USD/CAD, USD/JPY Forecasts – U.S. Dollar Gains Ground As GDP Growth Rate Beats Expectations
about 3 hours ago
Nasdaq 100, Dow Jones, S&P 500 News: Wall Street Eyes Record Highs in Q1, Buoyed by AI Surge, Fed Optimism
about 3 hours ago
Natural Gas Price Forecast – Natural Gas Continues to Sit at Support
about 4 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
IOVA
news
Iovance Biotherapeutics Inc
Follow
IOVA
(
Nasdaq - US
)
Open
14.87
+0.77 (+5.46%)
in
:
usd
•
As of: Mar 28, 2024 14:39
UTC -4
Open
14.20
High
15.18
Low
14.15
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
The Motley Fool
Mar 26, 2024
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
IOVA
+5.46%
VKTX
-1.74%
Seeking Alpha
Mar 25, 2024
Rise Of The Rest, Look Past Mega Caps, And Invest Elsewhere
IOVA
+5.46%
META
-1.29%
VKTX
-1.74%
InvestorPlace
Mar 19, 2024
7 Biotech Stocks Ready to Ride the Sector's Resurgence
IOVA
+5.46%
TECH
+1.63%
The Motley Fool
Mar 7, 2024
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
IOVA
+5.46%
The Motley Fool
Mar 6, 2024
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
IOVA
+5.46%
Zacks Investment Research
Mar 5, 2024
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
IOVA
+5.46%
The Motley Fool
Mar 2, 2024
Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
IOVA
+5.46%
The Motley Fool
Feb 29, 2024
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
IOVA
+5.46%
Zacks Investment Research
Feb 29, 2024
Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates
IOVA
+5.46%
The Motley Fool
Feb 29, 2024
Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
IOVA
+5.46%
Zacks Investment Research
Feb 28, 2024
Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates
IOVA
+5.46%
Seeking Alpha
Feb 28, 2024
Iovance Biotherapeutics, Inc. (IOVA) Q4 2023 Earnings Call Transcript
IOVA
+5.46%
Zacks Investment Research
Feb 27, 2024
Why Iovance (IOVA) Might Surprise This Earnings Season
IOVA
+5.46%
24/7 Wall Street
Feb 27, 2024
Stock Offerings Prompt Big Insider Buying
IOVA
+5.46%
InvestorPlace
Feb 27, 2024
3 Stocks Flashing Recent Insider Buying Signals
IOVA
+5.46%
INTC
+0.80%
InvestorPlace
Feb 26, 2024
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
IOVA
+5.46%
The Motley Fool
Feb 26, 2024
1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street
IOVA
+5.46%
The Motley Fool
Feb 25, 2024
Is Iovance a Buy After Its First Regulatory Win?
IOVA
+5.46%
The Motley Fool
Feb 23, 2024
This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst
IOVA
+5.46%
The Motley Fool
Feb 23, 2024
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
IOVA
+5.46%
DNA
+6.82%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker